Drug and alcohol review · 2026
Etomidate-Adulterated Vaping: Fragmented Global Drug Control and Public Health Risks.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lassi Nicholas, Jiang Su
Аннотация
ISSUE: This study examines the spread of etomidate-adulterated vaping products ('k-pods', 'space oil' or 'zombie cigarettes') and compares legal and policy responses across affected jurisdictions.
APPROACH: Through a review of government reports, forensic data and statutory instruments, the analysis reconstructs the geographic spread of etomidate and its analogues, evaluates their toxicological hazards when aerosolised, and contrasts divergent regulatory strategies.
KEY FINDINGS: Findings show that detection and enforcement are concentrated in East and Southeast Asia, where jurisdictions vary between criminal-control and pharmaceutical-control models. The study recommends three interlocking reforms: (i) adoption of broad-spectrum analogue legislation; (ii) investment in regional forensic infrastructure; and (iii) enhanced real-time information-sharing platforms. These measures would close regulatory loopholes, strengthen surveillance and prosecution, preserve legitimate clinical access, and reduce illicit manufacture, distribution and online commercialisation of etomidate-contaminated vaping products.
CONCLUSIONS: Etomidate-adulterated vaping constitutes an international governance and public health challenge that is best countered through synchronised legal reform, enhanced forensic infrastructure and accelerated cross-jurisdictional intelligence sharing.
APPROACH: Through a review of government reports, forensic data and statutory instruments, the analysis reconstructs the geographic spread of etomidate and its analogues, evaluates their toxicological hazards when aerosolised, and contrasts divergent regulatory strategies.
KEY FINDINGS: Findings show that detection and enforcement are concentrated in East and Southeast Asia, where jurisdictions vary between criminal-control and pharmaceutical-control models. The study recommends three interlocking reforms: (i) adoption of broad-spectrum analogue legislation; (ii) investment in regional forensic infrastructure; and (iii) enhanced real-time information-sharing platforms. These measures would close regulatory loopholes, strengthen surveillance and prosecution, preserve legitimate clinical access, and reduce illicit manufacture, distribution and online commercialisation of etomidate-contaminated vaping products.
CONCLUSIONS: Etomidate-adulterated vaping constitutes an international governance and public health challenge that is best countered through synchronised legal reform, enhanced forensic infrastructure and accelerated cross-jurisdictional intelligence sharing.